Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Nephrology | Urology | Family Medicine
Disease Category: Prostate Cancer
Location: United States, ND
Clinical Trial Details
Research Study Summary
To demonstrate superiority in the overall survival of patients with progressive prostate cancer.
Patient Inclusion Criteria:
- Confirmed diagnosis of prostate cancer, patients must have surgical or ongoing chemical castration, patients must have disease that has failed one prior docetaxel-based chemotherapy regimen for the treatment of metastatic disease, disease progression
Patient Exclusion Criteria:
- Prior treatment with sunitinib and more than one prior chemotherapy regimen in the metastatic disease treatment setting, chemotherapy within 3 weeks of the date of the first dose.
To Learn more
Date Last Changed:
July 24, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.